Universal STAR-T Cell is named as a drug or biological intervention in 3 clinical trials in our China trial register, none of which are currently recruiting. Lead sponsors include Daishi Tian (2) and Guangdong Provincial People's Hospital (1). Registered phases: Phase 1 and Not applicable. Conditions studied include IgA Nephropathy (IgAN); Primary Membranous Nephropathy; Multiple Sclerosis (MS).
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07523100 | A Study on the Safety and Tolerability of Universal STAR-T Cell Therapy for Multiple Sclerosis. (ClinicalTrials.gov ↗) Multiple Sclerosis (MS) |
Phase 1 | Not yet open |
| NCT07714798 | Universal STAR-T Cell Injection in Generalized Myasthenia Gravis (ClinicalTrials.gov ↗) Generalized Myasthenia Gravis |
Phase 1 | Not yet open |
| NCT07746453 | Universal STAR-T Cell Injection in Autoimmune Kidney Diseases (ClinicalTrials.gov ↗) IgA Nephropathy (IgAN), Primary Membranous Nephropathy |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| IgA Nephropathy (IgAN) | 1 |
| Primary Membranous Nephropathy | 1 |
| Multiple Sclerosis (MS) | 1 |
| Generalized Myasthenia Gravis | 1 |
| Lead sponsor | Trials |
|---|---|
| Daishi Tian | 2 |
| Guangdong Provincial People's Hospital | 1 |
| Register | Universal STAR-T Cell trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Universal STAR-T Cell works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Universal STAR-T Cell (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.